Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 86151-86200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05797909
The PCOS Challenge Study
N/ARecruiting
15,000 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2042
1 condition1 sponsor1 location
NCT05510193
Redesign, Implementation and Evaluation of the Effectiveness of the Aktio Myoelectric Prosthesis
NAActive, not recruiting
10 participants
Started: Jun 22, 2022 · Completed: Dec 27, 2023
3 conditions2 sponsors2 locations
NCT05431530
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
N/ARecruiting
108 participants
Started: Jun 22, 2022 · Completed: May 31, 2027
3 conditions1 sponsor1 location
NCT05098704
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
PHASE2/PHASE3Recruiting
90 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2031
2 conditions2 sponsors10 locations
NCT04174755
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
NARecruiting
80 participants
Started: Jun 22, 2022 · Completed: Jan 31, 2026
2 conditions3 sponsors1 location
NCT05338801
Effect of Menthol on ENDS Users' Addiction and Exposure
NARecruiting
250 participants
Started: Jun 22, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05092984
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
PHASE3Recruiting
154 participants
Started: Jun 22, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05469945
Lymphedema After Gyneco-oncologic Treatment
NARecruiting
218 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2028
2 conditions3 sponsors2 locations
NCT05459415
Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC
NAActive, not recruiting
54 participants
Started: Jun 22, 2022 · Completed: Jun 21, 2027
3 conditions1 sponsor1 location
NCT05146336
CytOSorb TreatMent Of Critically Ill PatientS Registry
N/ARecruiting
3,000 participants
Started: Jun 22, 2022 · Completed: Sep 30, 2032
18 conditions1 sponsor28 locations
NCT05020028
Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
PHASE2/PHASE3Recruiting
100 participants
Started: Jun 22, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05505409
Efficacy and Safety of Pirfenidone in CTD-ILD
PHASE4Recruiting
120 participants
Started: Jun 22, 2022 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT05222828
Effects of Mepivacaine on the Neurological Sequelae of Cerebral Infarction
PHASE2Recruiting
38 participants
Started: Jun 22, 2022 · Completed: Jun 22, 2024
1 condition1 sponsor1 location
NCT05416905
Deep Brain Stimulation for Idiopathic Craniofacial Dystonia: GPi or STN
NARecruiting
110 participants
Started: Jun 22, 2022 · Completed: May 30, 2025
2 conditions9 sponsors1 location
NCT05251675
Effect of Physician Peer Coaching on Burnout in Hospital-Based Physicians: A Pilot Randomized Clinical Trial
NAActive, not recruiting
50 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06850922
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
PHASE1/PHASE2Recruiting
546 participants
Started: Jun 22, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor73 locations
NCT06220890
Clinical Performance of Two Different Bevel Preparations in Class IV Lesions Using Nanofilled Composite
NAActive, not recruiting
100 participants
Started: Jun 22, 2022 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT06102018
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
N/ARecruiting
150 participants
Started: Jun 22, 2022 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT06040489
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
PHASE2/PHASE3Recruiting
100 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05975190
Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer
NARecruiting
108 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05126758
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
PHASE3Active, not recruiting
104 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2027
8 conditions1 sponsor20 locations
NCT05147506
Digital Therapeutic for Depression After Head Injury in Current and Former US Military Personnel
NAActive, not recruiting
113 participants
Started: Jun 22, 2022 · Completed: Jan 1, 2025
2 conditions1 sponsor1 location
NCT05138991
Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors
NAActive, not recruiting
149 participants
Started: Jun 22, 2022 · Completed: Jul 16, 2026
2 conditions2 sponsors1 location
NCT05416372
Engaging Religious Leaders to Reduce Blood Pressures in Tanzanian Communities
NARecruiting
24,000 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05513820
Automatic Detection in MRI of Prostate Cancer: DAICAP
N/ARecruiting
1,250 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2024
1 condition7 sponsors1 location
NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
PHASE1/PHASE2Active, not recruiting
6 participants
Started: Jun 21, 2022 · Completed: Oct 30, 2028
17 conditions1 sponsor7 locations
NCT05270499
Aveir VR Real-World Evidence Post-Approval Study
N/ARecruiting
2,100 participants
Started: Jun 21, 2022 · Completed: Feb 28, 2034
3 conditions1 sponsor1 location
NCT04926285
Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)
PHASE1Active, not recruiting
6 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05287737
Clinical Outcome After Total Pancreatectomy With Islet Autotransplantation
N/AEnrolling by invitation
100 participants
Started: Jun 21, 2022 · Completed: Mar 31, 2047
3 conditions1 sponsor1 location
NCT05197387
Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental Inflammation
N/ARecruiting
322 participants
Started: Jun 21, 2022 · Completed: Jun 22, 2025
1 condition1 sponsor11 locations
NCT05259046
The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health
NARecruiting
450 participants
Started: Jun 21, 2022 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT05235516
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
PHASE3Active, not recruiting
636 participants
Started: Jun 21, 2022 · Completed: May 31, 2029
1 condition1 sponsor9 locations
NCT05357170
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
N/ARecruiting
468 participants
Started: Jun 21, 2022 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT05336877
Aveir VR Coverage With Evidence Development Post-Approval Study
N/ARecruiting
8,744 participants
Started: Jun 21, 2022 · Completed: Jan 1, 2028
3 conditions1 sponsor1 location
NCT04901351
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NARecruiting
30 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04924803
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
NAActive, not recruiting
545 participants
Started: Jun 21, 2022 · Completed: Feb 27, 2026
1 condition3 sponsors1 location
NCT05314491
Multigen Plus CCK and AMF TT Cones Follow Up Study
N/ARecruiting
68 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2026
2 conditions1 sponsor3 locations
NCT05422222
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
PHASE3Recruiting
210 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2030
1 condition1 sponsor38 locations
NCT05008718
Silver Diamine Fluoride: A Randomized Controlled Trial on Its Effectiveness As A Caries Arresting Agent
NAActive, not recruiting
122 participants
Started: Jun 21, 2022 · Completed: Feb 29, 2024
2 conditions1 sponsor1 location
NCT05234177
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
N/ARecruiting
300 participants
Started: Jun 21, 2022 · Completed: Feb 28, 2029
1 condition1 sponsor20 locations
NCT05358938
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
EARLY_PHASE1Active, not recruiting
22 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06480994
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
N/ARecruiting
1,836 participants
Started: Jun 21, 2022 · Completed: Feb 28, 2027
3 conditions5 sponsors4 locations
NCT05340673
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
PHASE1Active, not recruiting
208 participants
Started: Jun 21, 2022 · Completed: Dec 21, 2025
2 conditions2 sponsors1 location
NCT05787795
Identifying and Characterizing Preclinical MS
N/ARecruiting
1,000 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2033
1 condition2 sponsors1 location
NCT05150093
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
NARecruiting
120 participants
Started: Jun 21, 2022 · Completed: Aug 31, 2026
4 conditions6 sponsors1 location
NCT05377424
Adenosine 2A Receptor Antagonism and AIH in ALS
PHASE1/PHASE2Recruiting
40 participants
Started: Jun 21, 2022 · Completed: May 31, 2026
1 condition2 sponsors2 locations
NCT04629053
Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
N/ARecruiting
7,200 participants
Started: Jun 21, 2022 · Completed: Dec 1, 2024
1 condition6 sponsors4 locations
NCT05296070
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
PHASE2Recruiting
50 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors4 locations
NCT05773937
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
PHASE1Recruiting
40 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT05430399
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
PHASE3Recruiting
349 participants
Started: Jun 21, 2022 · Completed: Jun 1, 2027
2 conditions3 sponsors2 locations